ExcelVite
Trending Articles
Related Content
Research & Development
Palm tocotrienol’s impact in postmenopausal osteoarthritis and osteoporosis
Both emulsified palm tocotrienol (EVNol SupraBio) and non-emulsified palm tocotrienol (EVNol) demonstrated protective effects on bone and joint health in ovariectomised rats suffering from osteoporosis and osteoarthritis
Ingredients
Bioenhanced mixed-tocotrienol complex offers 12-months of sustainable effect in non-proliferative diabetic retinopathy (NPDR)
The latest double-blind, randomised controlled study shows that tocotrienol supplementation at 200 mg twice a day for 12 months supports the improvement of early diabetic retinopathy by attenuating the progression of retinal micro-haemorrhage and diabetic macular oedema (DME)
Ingredients
Phase II clinical trial shows EVNol SupraBio attenuates retinal bleeding in diabetic retinopathy
A pilot phase II clinical trial revealed that 8 weeks of supplementation with EVNol SupraBio™ (encapsulated in softgels branded Tocovid SupraBio) resulted in a significant reduction in retinal haemorrhage in the right eye of diabetic retinopathy patients